Skip to content
ChickenStockChickenStock
ResearchEHC
Encompass Health logo

Encompass Health (EHC) stock

NYSE

$137.88-2.98%(-4.24)

As of the Nov 17, 2026 close (U.S. Eastern)

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 17, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

20.98x

P/B

5.04x

P/S

2.13x

Find stocks with P/B ≤ 0.9×

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q3)

Revenue increased 8.9% from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Nov 3, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

18 SEC filings
  • Reidy Christopher RDirector · Oct 19, 2026Grant or award284 shares · $36K
    Avg. price $126.8918,081 shares held after
  • Christie Edward M IIIDirector · Oct 19, 2026Grant or award221 shares · $28K
    Avg. price $126.639,577 shares held after
  • Williams TerranceDirector · Oct 15, 2026Grant or award28 shares · $0
    Avg. price $016,887 shares held after
  • HERMAN JOAN EDirector · Oct 15, 2026Grant or award81 shares · $0
    Avg. price $049,724 shares held after
  • Christie Edward M IIIDirector · Oct 15, 2026Grant or award11 shares · $0
    Avg. price $09,356 shares held after
  • Reidy Christopher RDirector · Oct 15, 2026Grant or award20 shares · $0
    Avg. price $017,797 shares held after
  • Hayes Cain ADirector · Oct 15, 2026Grant or award4 shares · $0
    Avg. price $02,100 shares held after
  • O'Connor Kevin J.Director · Oct 15, 2026Grant or award18 shares · $0
    Avg. price $011,600 shares held after
  • KATZ LESLYE GDirector · Oct 15, 2026Grant or award81 shares · $0
    Avg. price $049,724 shares held after
  • CARMICHAEL GREG DDirector · Oct 15, 2026Grant or award28 shares · $0
    Avg. price $020,377 shares held after
  • SCHLICHTING NANCY MDirector · Oct 15, 2026Grant or award38 shares · $0
    Avg. price $023,010 shares held after
  • Price Andrew LChief Accounting Officer · Aug 31, 2026Open-market sale5,211 shares · $630K
    Avg. price $120.9369,483 shares held after
  • Darby John PatrickEVP, Gen Counsel & Secretary · Aug 31, 2026Open-market sale4,858 shares · $588K
    Avg. price $121.0975,041 shares held after
  • Darby John PatrickEVP, Gen Counsel & Secretary · Aug 31, 2026Option exercise4,858 shares · $170K
    Avg. price $35.0679,899 shares held after
  • Tarr Mark JPresident & CEO · Aug 10, 2026Open-market sale173,148 shares · $21.7M
    Avg. price $125.4655
    Show 2 price lots
    • 171,569 shares × $125.46$21.5M
    • 1,579 shares × $126.06$199K
  • COLTHARP DOUGLAS EEVP & Chief Financial Officer · Aug 10, 2026Open-market sale18,869 shares · $2.4M
    Avg. price $125.3850,508 shares held after
  • Darby John PatrickEVP, Gen Counsel & Secretary · Aug 10, 2026Open-market sale8,906 shares · $1.1M
    Avg. price $125.9575,041 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Encompass Health (EHC) stock information

NYSE

Encompass Health (EHC) is listed on NYSE. Its market capitalization is about $13.5B. On trailing-twelve-month earnings the P/E ratio is 20.98, and the P/B ratio is 5.04. Return on equity is 24%. These figures are computed in-house from official filings and are reference information only.

Encompass Health — frequently asked questions

What is the P/E ratio of Encompass Health (EHC)?
On a trailing-twelve-month basis, EHC trades at a P/E ratio of 20.98. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Encompass Health?
EHC has a market capitalization of about $13.5B. The figure moves with the share price and is refreshed each trading day.
Does Encompass Health pay a dividend?
EHC has a dividend yield of about 0.52%, based on disclosed payment history. Dividend policy can change; this is reference information only.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.